Showing results (1-10 of 191) with videos related to
Sort By:
Pageof 20
The Journal of Antimicrobial Chemotherapy|October 27, 2012
Rilpivirine: a new non-nucleoside reverse transcriptase inhibitorMamta Sharma, Louis D SaravolatzClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2022
Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral DrugsLouis D Saravolatz, Shawn Depcinski, Mamta SharmaJac-Antimicrobial Resistance|May 29, 2026
<i>Candidozyma auris</i> susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agentsKatherine S Klamer, Ashish Bhargava, Leonard Johnson, et al.Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 28, 2022
Do risk factors at the time of hospital admission differ by sex for in-hospital mortality from coronavirus disease 2019 (COVID-19)?Mamta Sharma, Ashish Bhargava, Susanna M Szpunar, et al.Diagnostic Microbiology and Infectious Disease|October 28, 2018
VISA-Daptomycin non-susceptible Staphylococcus aureus frequently demonstrate non-susceptibility to TelavancinLouis D Saravolatz, Joan PawlakClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2003
Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolonesLouis D Saravolatz, James LeggettJac-Antimicrobial Resistance|July 5, 2024
Rhodomyrtone: a new anti-<i>Staphylococcus aureus</i> agent against resistant strainsLouis D Saravolatz, Joan PawlakThe Journal of Antimicrobial Chemotherapy|November 14, 2022
In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolidLouis D Saravolatz, Joan PawlakClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 2, 2020
The American Board of Internal Medicine's New Longitudinal Assessment Option and What It Means for Infectious Disease SpecialistsGeorge M Abraham, Louis D SaravolatzClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Delafloxacin: A New Anti-methicillin-resistant Staphylococcus aureus FluoroquinoloneLouis D Saravolatz, Gary E SteinPageof 20